Insider Transactions in Q3 2025 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2025
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,046
-1.46%
|
$14,092
$2.81 P/Share
|
|
Sep 17
2025
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
28,427
-1.84%
|
$56,854
$2.79 P/Share
|
|
Sep 17
2025
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
6,267
-1.57%
|
$12,534
$2.8 P/Share
|
|
Jul 17
2025
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11
-0.0%
|
$11
$1.12 P/Share
|
|
Jul 17
2025
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
1,304
-0.33%
|
$1,304
$1.13 P/Share
|